741520
Last Update Posted: 2010-10-28
Recruiting has ended
Males accepted | 30 Years-60 Years |
36 Estimated Participants | No Expanded Access |
Interventional Study | Accepts healthy volunteers |
Cardiovascular Impact of Obstructive Sleep Apnea Treatment in Normotensive Patients
Recent evidences suggest that obstructive sleep apnea (OSA) can contribute to cardiovascular disease even in the absence of hypertension. However, there are few data regarding the impact of OSA on the preHypertension and Masked Hypertension in apparently normotensive patients with OSA as well as the impact of treatment with continuous positive airway pressure.
Eligibility
Relevant conditions:
Obstructive Sleep Apnea
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov